Method of treating connective tissue defect using chondrocytes selected for phenotypic stability
View Patent ↗An in vivo assay to measure anchorage-independent growth and phenotypic stability of a certain cell population comprising subcutaneous or intramuscular injection in a mammal of a cell suspension of articular chondrocytes in an iso-osmotic liquid, the same suspension comprising articular chondrocytes in an amount equivalent to at least 1×10 6 chondrocytes as applied to immune-deficient mice. The outcome is linked to molecular markers. The present invention further relates to DNA chips and diagnostic tools comprising the latter to predict the outcome of ACT. Antibodies raised against positive and negative markers of chondrocyte stability can also be used for quality control on the chondrocytes. Therapeutical composition comprising stable chondrocytes are very useful for tissue repair.
1. A method of treating a connective tissue defect in a patient comprising the step of transplanting chondrocytes to a connective tissue site in a patient, using passaged chondrocytes that have been prepared using the method steps of :
a) providing articular cartilage from said patient
b) isolating chondrocytes from said articular cartilage by enzymatic digestion
c) expanding said isolated chondrocytes by serial passaging,
d1) detecting in said passaged chondrocytes the expression of bone morphogenic protein-2(BMP-2), fibroblast growth factor receptor 3 (FGFR-3), or Collagen type II, or
d2) detecting in said passaged chondrocytes the expression of activin-like kinase-1 (ALK-1) or Collagen type X
e) selecting a cell population of passaged chondrocytes wherein a cell population that has either (1) expression of BMP-2, FGR-3 or collagen type II or has (2) no expression of Collagen Type X or no expression of ALK-1 is selected,
f) transplanting said cell population to a connective tissue site in said patient.
2. The method according to claim 1 , wherein said expression is detected by means of a monoclonal or polyclonal antibody against a negative or positive marker.
3. The method according to claim 1 , further comprising the step seeding a prosthetic device intended to be anchored into a mammal with said selected cell population.